Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Sayer Kevin R, Chief Executive Officer. Officer active across 1 company, notably DEXCOM INC. Cumulatively, 32 reports have been recorded. Split: 0 buy · 21 sells. Total volume traded: €31.7m. History available since 3 May 2021. The latest transaction was disclosed on 20 August 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Sayer Kevin R
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3,000 shares@ US$438.813.7% of flowCommon StockSEC:0001093557-22-000002:0
25 of 32 declarations
About Sayer Kevin R
SAYER KEVIN R is Directeur Général and Executive Chair at DEXCOM INC (XNAS). He has filed 28 reports in total, and across the 28 sampled filings between 2016-01-22 and 2026-07-07, the transactions are all sales, with a combined amount of EUR 29660082; the largest reported filings concern DEXCOM INC, including EUR 4652686.856127085 on 2023-01-31, EUR 4451655.710971985 on 2023-01-24, EUR 3648805.579981526 on 2024-03-14, EUR 3463370.676503722 on 2024-04-10, EUR 3239866.470154298 on 2023-03-02, and EUR 2095635.613607376 on 2025-03-14.